36 people in South Korea died after being vaccinated against influenza

 36 people in South Korea died after being vaccinated against influenza

Since June 16, a 17-year-old boy in Incheon died two days after being vaccinated with influenza vaccine, there have been cases of death after influenza vaccination in all parts of South Korea, most of whom are over 70 years old. The shortest death time was 4 hours after vaccination, and the longest was 85 hours after vaccination.

On the 21st, the Korean disease management agency held an emergency press conference on the situation, saying it was not clear whether there was a direct causal relationship between death cases and vaccination, and it was too early to stop vaccination.

Increasing deaths and a sharp drop in the number of people vaccinated against influenza in South Korea (Yonhap)

To prevent the novel coronavirus pneumonia and double infection of new crown and winter in autumn and winter, the Korean government decided in September this year to vaccinate influenza vaccine for people under 18 and over 65 years of age, covering 19 million people. However, just one day before the launch of the free vaccination program, due to the failure of the cold insulation of the vehicles transporting the influenza vaccine, which exposed the vaccine to normal temperature, the Korean disease administration stopped the free vaccination program and recovered 480000 vaccines. Another pharmaceutical company also voluntarily recalled 615000 vaccines with white particles in circulation.

(function(){( window.slotbydup=window .slotbydup||[]).push({id:u5811557,container:ssp_ 5811557, async:true }According to the information map, the influenza vaccine used in the free vaccination program in South Korea is supplied by five pharmaceutical enterprises, namely GC pharmaceutical company, SK biotechnology, Yiyang pharmaceutical company, Sanofi group in France and GlaxoSmithKline in the UK. Distributors include LG Chemical Company and Baoning pharmaceutical company. (Liu Qiang, overseas website) source: global.com editor in charge: Kang Ruixin_ NB16727

Information map